Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;35(12):2533-9.
doi: 10.2337/dc12-0572. Epub 2012 Aug 21.

Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement

Affiliations

Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement

Leonard E Egede et al. Diabetes Care. 2012 Dec.

Abstract

Objective: To examine the longitudinal effects of medication nonadherence (MNA) on key costs and estimate potential savings from increased adherence using a novel methodology that accounts for shared correlation among cost categories.

Research design and methods: Veterans with type 2 diabetes (740,195) were followed from January 2002 until death, loss to follow-up, or December 2006. A novel multivariate, generalized, linear, mixed modeling approach was used to assess the differential effect of MNA, defined as medication possession ratio (MPR) ≥0.8 on healthcare costs. A sensitivity analysis was performed to assess potential cost savings at different MNA levels using the Consumer Price Index to adjust estimates to 2012 dollar value.

Results: Mean MPR for the full sample over 5 years was 0.78, with a mean of 0.93 for the adherent group and 0.58 for the MNA group. In fully adjusted models, all annual cost categories increased ∼3% per year (P = 0.001) during the 5-year study time period. MNA was associated with a 37% lower pharmacy cost, 7% lower outpatient cost, and 41% higher inpatient cost. Based on sensitivity analyses, improving adherence in the MNA group would result in annual estimated cost savings ranging from ∼$661 million (MPR <0.6 vs. ≥0.6) to ∼$1.16 billion (MPR <1 vs. 1). Maximal incremental annual savings would occur by raising MPR from <0.8 to ≥0.8 ($204,530,778) among MNA subjects.

Conclusions: Aggressive strategies and policies are needed to achieve optimal medication adherence in diabetes. Such approaches may further the so-called "triple aim" of achieving better health, better quality care, and lower cost.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trajectory of mean costs from the unadjusted, shared, random intercept log-normal GLMM (in $1,000 units) for each cost type over time by medication adherence status (veterans with type 2 diabetes 2002–2006). (A high-quality color representation of this figure is available in the online issue.)

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and Estimates on Diabetes in the United States Atlanta, GA, U.S. Department of Health and Human Services, 2011. Available from http://www.cdc.gov/diabetes/pubs/factsheet11.htm
    1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114–2116 - PubMed
    1. Agency for Healthcare Quality and Research. 2010 National Health Disparities Report Rockville, MD, U.S. Department of Health and Human Services, 2010 (Rep. no. 11-0005). Available from http://www.cbo.gov/publication/41656
    1. Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association. European Association for Study of Diabetes Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193–203 - PMC - PubMed
    1. U.S. Department of Veterans Affairs. VA/DoD clinical practice guidleline for the management of diabetes [Internet], 2011. Available from http://www.healthquality.va.gov/diabetes/DM2010_FUL-v4e.pdf Accessed 6 December 2011

Publication types

MeSH terms

Substances